Literature DB >> 25447944

Role of synucleins in traumatic brain injury — an experimental in vitro and in vivo study in mice.

Irina Surgucheva, Shuangteng He, Megan C Rich, Ram Sharma, Natalia N Ninkina, Philip F Stahel, Andrei Surguchov.   

Abstract

Synucleins are small prone to aggregate proteins associated with several neurodegenerative diseases (NDDs), however their role in traumatic brain injury (TBI) is an emerging area of investigation. Using in vitro scratch injury model and in vivo mouse weight-drop model we have found that the injury causes alterations in the expression and localization of synucleins near the damaged area. Before injury, α-synuclein is diffused in the cytoplasm of neurons and γ-synuclein is both in the cytoplasm and nucleus of oligodendrocytes. After the scratch injury of the mixed neuronal and glial culture, α-synuclein forms punctate structures in the cytoplasm of neurons and γ-synuclein is almost completely localized to the nucleus of the oligodendrocytes. Furthermore, the amount of post-translationally modified Met38-oxidized γ-synuclein is increased 3.8 fold 24 h after the scratch. α- and γ-synuclein containing cells increased in the initially cell free scratch zone up to 24 h after the scratch.Intracellular expression and localization of synucleins are also changed in a mouse model of focal closed head injury, using a standardized weight drop device. γ-Synuclein goes from diffuse to punctate staining in a piriform cortex near the amygdala, which may reflect the first steps in the formation of deposits/inclusions. Surprisingly, oxidized γ-synuclein co-localizes with cofilin-actin rods in the thalamus, which are absent in all other regions of the brain. These structures reach their peak amounts 7 days after injury. The changes in γ-synuclein localization are accompanied by injury-induced alterations in the morphology of both astrocytes and neurons.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25447944     DOI: 10.1016/j.mcn.2014.10.005

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  19 in total

1.  Head injury serum markers for assessing response to trauma: Design of the HeadSMART study.

Authors:  Matthew E Peters; Vani Rao; Kathleen T Bechtold; Durga Roy; Haris I Sair; Jeannie-Marie Leoutsakos; Ramon Diaz-Arrastia; Robert D Stevens; D Scott Batty; Hayley Falk; Christopher Fernandez; Uju Ofoche; Alexandra Vassila; Anna J Hall; Braden Anderson; Edward Bessman; Constantine G Lyketsos; Allen D Everett; Jennifer Van Eyk; Frederick K Korley
Journal:  Brain Inj       Date:  2017-01-31       Impact factor: 2.311

2.  Detection of autoantibodies to potentially amyloidogenic protein, gamma-synuclein, in the serum of patients with amyotrophic lateral sclerosis and cerebral circulatory disorders.

Authors:  A Yu Roman; E A Kovrazhkina; O D Razinskaya; M S Kukharsky; A V Maltsev; R K Ovchinnikov; O A Lytkina; A P Smirnov; A A Moskovtsev; Yu V Borodina; A P Surguchov; A A Ustyugov; N N Ninkina; V I Skvortsova
Journal:  Dokl Biochem Biophys       Date:  2017-04-19       Impact factor: 0.788

Review 3.  Genetics of synucleins in neurodegenerative diseases.

Authors:  José Brás; Elizabeth Gibbons; Rita Guerreiro
Journal:  Acta Neuropathol       Date:  2020-08-01       Impact factor: 17.088

4.  Acrolein-mediated alpha-synuclein pathology involvement in the early post-injury pathogenesis of mild blast-induced Parkinsonian neurodegeneration.

Authors:  Glen Acosta; Nicholas Race; Seth Herr; Joseph Fernandez; Jonathan Tang; Edmond Rogers; Riyi Shi
Journal:  Mol Cell Neurosci       Date:  2019-06-12       Impact factor: 4.314

5.  Reducing synuclein accumulation improves neuronal survival after spinal cord injury.

Authors:  Stephanie M Fogerson; Alexandra J van Brummen; David J Busch; Scott R Allen; Robin Roychaudhuri; Susan M L Banks; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan; Jennifer R Morgan
Journal:  Exp Neurol       Date:  2016-02-13       Impact factor: 5.330

6.  Tat-p27 Ameliorates Neuronal Damage Reducing α-Synuclein and Inflammatory Responses in Motor Neurons After Spinal Cord Ischemia.

Authors:  Woosuk Kim; Hyun Jung Kwon; Hyo Young Jung; Kyu Ri Hahn; Seung Myung Moon; Yeo Sung Yoon; In Koo Hwang; Soo Young Choi; Dae Won Kim
Journal:  Neurochem Res       Date:  2021-08-17       Impact factor: 3.996

7.  The role of alpha-synuclein in the development of the dopaminergic neurons in the substantia nigra and ventral tegmental area.

Authors:  T V Tarasova; O A Lytkina; A Yu Roman; S O Bachurin; A A Ustyugov
Journal:  Dokl Biol Sci       Date:  2016-03-30

8.  Effects of Aerobic Exercise on Tau and Related Proteins in Rats with the Middle Cerebral Artery Occlusion.

Authors:  Sakulrat Mankhong; Sujin Kim; Sohee Moon; Kyoung-Hee Lee; Hyeong-Eun Jeon; Byeong-Hun Hwang; Jong-Won Beak; Kyung-Lim Joa; Ju-Hee Kang
Journal:  Int J Mol Sci       Date:  2020-08-14       Impact factor: 5.923

Review 9.  Exosomes in Alzheimer's Disease: Potential Role as Pathological Mediators, Biomarkers and Therapeutic Targets.

Authors:  Sreeja Lakshmi; Musthafa Mohamed Essa; Richard E Hartman; Gilles J Guillemin; Sureshkumar Sivan; Preetham Elumalai
Journal:  Neurochem Res       Date:  2020-08-25       Impact factor: 3.996

10.  Examining Microstructural White Matter in Active Duty Soldiers with a History of Mild Traumatic Brain Injury and Traumatic Stress.

Authors:  Michael N Dretsch; Rael T Lange; Jeffery S Katz; Adam Goodman; Thomas A Daniel; Gopikrishna Deshpande; Thomas S Denney; Grant L Iverson; Jennifer L Robinson
Journal:  Open Neuroimag J       Date:  2017-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.